RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
American journal of human genetics.
Times cited: 175
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Times cited: 1262